ITGAX and hepatocellular carcinoma: Moreover, multivariate survival analysis revealed that only TNM stage (P < 0.001), BCLC stage (P = 0.007), CD11c‐positive expression (P < 0.001) and CD206‐positive (P = 0.031) expression were identified as independent predictors of poor prognosis for OS in HCC patients after adjustment of covariates (Table 3).